4//SEC Filing
Spellman David A 4
Accession 0001104659-18-017502
CIK 0001442836other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:49 PM ET
Size
5.3 KB
Accession
0001104659-18-017502
Insider Transaction Report
Form 4
Spellman David A
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2018-03-12+150,000→ 150,000 totalExercise: $13.97Exp: 2021-03-12→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The option will vest as to 25% of the shares on the first anniversary of the grant date and in equal quarterly installments over the next three years.
Documents
Issuer
Mersana Therapeutics, Inc.
CIK 0001442836
Entity typeother
Related Parties
1- filerCIK 0001733204
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 4:49 PM ET
- Size
- 5.3 KB